CymitQuimica logo

CAS 618913-30-7

:

Formel:C10H12N4O2S
InChl:InChI=1S/C10H12N4O2S/c15-9-7-8(12-5-11-7)14(10(17)13-9)4-6-2-1-3-16-6/h5-6H,1-4H2,(H,11,12)(H,13,15,17)/t6-/m1/s1
InChI Key:RSPDBEVKURKEII-ZCFIWIBFSA-N
SMILES:C1C[C@@H](OC1)CN2C3=C(C(=O)NC2=S)NC=N3
6 Produkte gefunden.
  • AZD5904

    CAS:
    AZD5904 is a potent and irreversible inhibitor of human Myeloperoxidase (MPO, IC50: 140 nM) which has similar potency in mouse and rat.
    Formel:C10H12N4O2S
    Reinheit:99.89%
    Farbe und Form:Solid
    Molekulargewicht:252.293
  • (R)-3-((Tetrahydrofuran-2-Yl)Methyl)-2-Thioxo-1,2,3,9-Tetrahydro-6H-Purin-6-One

    CAS:
    (R)-3-((Tetrahydrofuran-2-Yl)Methyl)-2-Thioxo-1,2,3,9-Tetrahydro-6H-Purin-6-One
    Formel:C10H12N4O2S
    Reinheit:98%
    Molekulargewicht:252.29

    Ref: 54-OR1022969

    25mg
    210,00€
  • AZD5904

    CAS:
    AZD5904
    Formel:C10H12N4O2S
    Reinheit:≥98%
    Molekulargewicht:252.29

    Ref: 54-BUP04827

    1mg
    51,00€
    5mg
    96,00€
    10mg
    180,00€
    25mg
    377,00€
    50mg
    657,00€
    100mg
    989,00€
  • (R)-3-((Tetrahydrofuran-2-Yl)Methyl)-2-Thioxo-1,2,3,9-Tetrahydro-6H-Purin-6-One

    CAS:
    Formel:C10H12N4O2S
    Reinheit:98%
    Farbe und Form:Solid
    Molekulargewicht:252.2929

    Ref: IN-DA01EOFS

    1mg
    129,00€
    5mg
    179,00€
    10mg
    262,00€
    25mg
    563,00€
    50mg
    627,00€
    100mg
    1.028,00€
  • AZD5904

    CAS:
    (R)-3-((Tetrahydrofuran-2-yl)methyl)-2-thioxo-1,2,3,9-tetrahydro-6H-purin-6-one
    Formel:C10H12N4O2S
    Reinheit:98%
    Molekulargewicht:252.29
  • AZD5904

    CAS:
    AZD5904 is a specific treatment that inhibits the enzyme hypochlorous acid (HOCl) and may be used to treat inflammatory diseases. HOCl is an oxidant that can be produced by neutrophils and macrophages, which has been shown to have a role in insulin sensitivity. AZD5904 has been shown to inhibit the production of HOCl in rats with diabetes mellitus type 2 and may also be useful for the treatment of cardiac hypertrophy. A study was conducted using Sprague-Dawley rats, which were given AZD5904. The rats were first incubated with glucose, then injected with insulin. The rats showed reduced levels of glucose after receiving AZD5904 as compared to control groups that did not receive the drug. The study concluded that AZD5904 inhibited insulin sensitivity, thereby reducing blood glucose levels in diabetic models.
    Formel:C10H12N4O2S
    Reinheit:Min. 95%
    Molekulargewicht:252.29 g/mol

    Ref: 3D-TZA91330

    25mg
    1.002,00€
    50mg
    1.315,00€
    100mg
    2.048,00€